Director, Oncology Trial Activation & Finance

ochsner; New Orleans (LA); Vor Ort; USD 140.000 - 190.000; Vollzeit

Zusammenfassung

Ochsner Health in New Orleans seeks a Director – Oncology Research Finance to lead end-to-end activation of oncology clinical trials and drive financial performance across startup, budgets, contracts, and regulatory processes.

The role requires strategic leadership, cross-functional collaboration, and a track record in CTMS systems integration, OnCore/EPIC workflows, and scalable infrastructure to support institutional growth.

Qualifikationen

• Bachelor’s degree required; Master’s preferred
• 6+ years clinical research administration experience
• 6+ years oncology research operations strongly preferred
• Experience with budgets, contracts, regulatory startup, CTMS systems
• Experience leading cross-functional teams

Aufgaben

• Direct oncology trial activation operations from feasibility through site activation.
• Establish startup performance metrics, dashboards, and accountability standards.
• Identify delays across budgeting, contracting, regulatory, committee review, and system build processes.
• Lead process redesign initiatives to reduce activation cycle times.
• Ensure timely movement through PRMC, IRB, coverage analysis, budgeting, contracting, and system builds
• Provide leadership for portfolio optimization and staffing
• Coordinate activation milestones across departments

Kenntnisse

Leadership

Cross-functional teams

Budgeting

Contract management

CTMS systems

Ausbildung

Bachelor’s degree

Master’s degree preferred

Tools

OnCore

EPIC integration

Jobbeschreibung

Ochsner Health in New Orleans seeks a Director – Oncology Research Finance to lead end-to-end activation of oncology clinical trials and drive financial performance across startup, budgets, contracts, and regulatory processes.

The role requires strategic leadership, cross-functional collaboration, and a track record in CTMS systems integration, OnCore/EPIC workflows, and scalable infrastructure to support institutional growth.